Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (20)
2024
-
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?
Annals of Hematology, Vol. 103, Núm. 8, pp. 2845-2851
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
-
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer
Clinical Cancer Research, Vol. 30, Núm. 14, pp. 3036-3049
2019
-
Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance
Lung Cancer, Vol. 134, pp. 72-78
-
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
Annals of Oncology, Vol. 30, Núm. 2, pp. 290-296
-
POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas
Journal of the American Heart Association, Vol. 8, Núm. 18, pp. e012875
-
Phase I/II trial to evaluate the efficacy and safety of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with pancreatic cancer and an ECOG performance status of 2
Journal of Clinical Oncology
-
Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3
Cell Reports, Vol. 27, Núm. 13, pp. 3956-3971.e6
2016
2015
-
Proteomic analysis of connexin 43 reveals novel interactors related to osteoarthritis
Molecular and Cellular Proteomics, Vol. 14, Núm. 7, pp. 1831-1845
-
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): A randomized, noninferiority phase II trialwith a pharmacogenetic analysis
Oncologist, Vol. 20, Núm. 2, pp. 111-112
2014
-
Lipoprotein(a) levels in familial hypercholesterolemia: An important predictor of cardiovascular disease independent of the type of LDL receptor mutation
Journal of the American College of Cardiology, Vol. 63, Núm. 19, pp. 1982-1989
-
Sky1 regulates the expression of sulfur metabolism genes in response to cisplatin
Microbiology (United Kingdom), Vol. 160, Núm. PART 7, pp. 1357-1368
2013
2012
-
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Breast Cancer Research and Treatment, Vol. 132, Núm. 1, pp. 307-315
2010
-
The transcriptional response of normal and rheumatoid arthritis synovial fibroblasts to hypoxia
Arthritis Care and Research, Vol. 62, Núm. 12, pp. 3584-3594
2008
-
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain
Clinical Cancer Research, Vol. 14, Núm. 9, pp. 2861-2869
2005
-
Critically short telomeres are associated with sperm DNA fragmentation
Fertility and Sterility, Vol. 84, Núm. 4, pp. 843-845
2002
-
T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: Differential diagnosis from Hodgkin's lymphoma
Histopathology, Vol. 41, Núm. 3, pp. 216-229